Skip to content

Prevention of relapse to heroin by transcutaneous acupoint electrical stimulation: a prospective study

Prevention of relapse to heroin by transcutaneous acupoint electrical stimulation: a prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001005
Enrollment
Unknown
Registered
2010-09-08
Start date
2009-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid drug addiction

Interventions

Sponsors

Neuroscience Research Institute, Peking University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Previous opioid addicts back to the society for less than six months and willing to accept community rehabilitation service; 2. Aged from 18 to 55, without gender limitation; 3. Person addicted mainly to opioid drugs; 4. Qualitative urine analysis on opioids showing negative result on the day of admission; 5. Fully understood and signed on informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with serious liver and kidney dysfunction, pulmonary decompensation, or complicated with serious damage in other systems; 2. Patients with serious infectious disease; 3. Patients with history of serious neurological or psychiatrical diseases; 4. Person with history of HIV infection or serious malnutrition; 5. Dependent upon and addicted to multiple drugs; 6. Attended some other drug trials within one month; 7. Women with pregnancy or with possibility of pregnancy, or in nursing period.

Design outcomes

Primary

MeasureTime frame
Relapse rate;

Secondary

MeasureTime frame
Anxiety scorse;Depression scorse;Protracted withdrawal symptoms scorse;

Countries

China

Contacts

Public ContactJisheng Han
hanjisheng@bjmu.edu.cn+86 10 82801109

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026